Cardinal Health (NYSE:CAH) Stock Rating Upgraded by Wall Street Zen

Cardinal Health (NYSE:CAH) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

CAH has been the subject of a number of other research reports. Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. TD Cowen raised their price target on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Wells Fargo & Company dropped their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Citigroup reiterated a “buy” rating on shares of Cardinal Health in a research report on Thursday. Finally, Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a research note on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $247.80.

Cardinal Health Trading Down 0.1%

Shares of NYSE:CAH opened at $238.79 on Friday. The company has a market cap of $55.93 billion, a price-to-earnings ratio of 36.51, a PEG ratio of 1.17 and a beta of 0.49. Cardinal Health has a 12 month low of $137.75 and a 12 month high of $240.93. The company has a 50-day moving average price of $208.99 and a 200 day moving average price of $211.70.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the firm posted $2.35 earnings per share. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts forecast that Cardinal Health will post 10.76 EPS for the current year.

Institutional Trading of Cardinal Health

A number of large investors have recently made changes to their positions in CAH. Integrated Wealth Concepts LLC boosted its position in Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after buying an additional 280 shares during the period. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in shares of Cardinal Health during the second quarter worth approximately $1,935,000. Cerity Partners LLC increased its position in shares of Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after acquiring an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC raised its stake in shares of Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.